Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,904 | 186 | 96.5% |
| Education | $104.95 | 2 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $356.92 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $309.93 | 17 | $0 (2024) |
| PFIZER INC. | $305.29 | 43 | $0 (2021) |
| Exact Sciences Corporation | $250.18 | 8 | $0 (2024) |
| Allergan, Inc. | $216.58 | 9 | $0 (2020) |
| Novo Nordisk Inc | $214.03 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $194.75 | 6 | $0 (2024) |
| Lilly USA, LLC | $133.55 | 9 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $130.10 | 17 | $0 (2019) |
| Amgen Inc. | $109.42 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $472.07 | 19 | Bayer Healthcare Pharmaceuticals Inc. ($205.39) |
| 2023 | $382.42 | 19 | Exact Sciences Corporation ($148.78) |
| 2022 | $186.67 | 11 | AstraZeneca Pharmaceuticals LP ($81.02) |
| 2021 | $318.97 | 14 | Astellas Pharma US Inc ($99.95) |
| 2020 | $400.80 | 23 | Novo Nordisk Inc ($136.91) |
| 2019 | $160.31 | 10 | Radius Health, Inc. ($48.89) |
| 2018 | $177.06 | 13 | GlaxoSmithKline, LLC. ($30.25) |
| 2017 | $910.60 | 79 | Allergan Inc. ($187.84) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 4 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/23/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Neuroscience | ||||||
| 06/25/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 06/10/2020 | PFIZER INC. | FLECTOR (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 05/20/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Diabetes | ||||||
| 05/13/2020 | PFIZER INC. | FLECTOR (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 03/05/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: GASTROINTESTINAL | ||||||
| 03/03/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Diabetes | ||||||
| 02/07/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Neuroscience | ||||||
| 01/28/2020 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Endocrinology | ||||||
| 01/14/2020 | PFIZER INC. | LYRICA (Drug), FLECTOR, COLOGUARD | Food and Beverage | In-kind items and services | $2.70 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/30/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2019 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Diabetes | ||||||
| 08/09/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: UROLOGY | ||||||
| 07/12/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Endocrinology | ||||||
| 07/02/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: UROLOGY | ||||||
| 06/18/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 05/31/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Bone Health | ||||||
| 05/17/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/13/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: DERMATOLOGY | ||||||
| 02/04/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Endocrinology | ||||||
| 11/09/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/21/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/07/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,145 | 4,144 | $432,954 | $197,551 |
| 2022 | 23 | 1,299 | 4,317 | $458,954 | $219,831 |
| 2021 | 22 | 2,107 | 4,550 | $396,518 | $165,930 |
| 2020 | 21 | 1,738 | 6,182 | $576,498 | $229,704 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 281 | 2,415 | $225,803 | $102,380 | 45.3% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 270 | 497 | $98,406 | $46,728 | 47.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 189 | $34,304 | $16,570 | 48.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 43 | $8,845 | $5,383 | 60.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $7,332 | $5,363 | 73.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 35 | 151 | $12,458 | $5,266 | 42.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 23 | 97 | $9,603 | $3,368 | 35.1% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 41 | 47 | $9,306 | $2,503 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $6,788 | $2,451 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 36 | $4,215 | $2,017 | 47.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 23 | 54 | $4,752 | $1,551 | 32.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 58 | 131 | $3,603 | $1,247 | 34.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 45 | 45 | $1,584 | $800.10 | 50.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 44 | 44 | $1,549 | $782.32 | 50.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 41 | 45 | $1,998 | $388.98 | 19.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 56 | 75 | $408.75 | $255.75 | 62.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 26 | $1,101 | $234.76 | 21.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 13 | 13 | $286.00 | $210.86 | 73.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 56 | $448.00 | $41.43 | 9.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 112 | $168.00 | $9.41 | 5.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 297 | 2,107 | $197,005 | $100,660 | 51.1% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 307 | 543 | $107,514 | $50,964 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 247 | $44,831 | $21,192 | 47.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 44 | 243 | $24,057 | $9,643 | 40.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 41 | 257 | $21,203 | $9,402 | 44.3% |
About Dr. Dawn Walker, DO
Dr. Dawn Walker, DO is a Family Medicine healthcare provider based in Willcox, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306895529.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dawn Walker, DO has received a total of $3,009 in payments from pharmaceutical and medical device companies, with $472.07 received in 2024. These payments were reported across 188 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,904).
As a Medicare-enrolled provider, Walker has provided services to 6,289 Medicare beneficiaries, totaling 19,193 services with total Medicare billing of $813,015. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Willcox, AZ
- Active Since 05/06/2006
- Last Updated 05/20/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306895529
Products in Payments
- Kerendia (Drug) $356.92
- Cologuard Collection Kit (Device) $250.18
- FARXIGA (Drug) $127.63
- VIBERZI (Drug) $125.23
- FLECTOR (Drug) $114.65
- Ozempic (Drug) $90.84
- RYBELSUS (Drug) $87.83
- BEVESPI AEROSPHERE (Drug) $86.35
- Tymlos (Biological) $76.51
- XARELTO (Drug) $71.67
- JARDIANCE (Drug) $65.92
- TRULICITY (Drug) $63.07
- VRAYLAR (Drug) $59.55
- INVOKANA (Drug) $58.43
- LYRICA (Drug) $57.87
- EMGALITY (Drug) $47.40
- Myrbetriq (Drug) $43.67
- COLOGUARD DNA CAPTURE REAGENTS (Device) $41.09
- Vascepa (Drug) $40.77
- Repatha (Biological) $40.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.